Eli Lilly to Consumers Following $75 Million Prescription Drug Robbery: Check Your Medicines

Eli Lilly and Company has issued a statement and details regarding the stolen company products from its distribution operations in Enfield, Connecticut on Sunday, March 14. Lilly is working with the U.S. Food and Drug Administration and other law enforcement officials to recover cases of select lots of pharmaceutical products that were stolen from one of Lilly’s U.S. distribution centers in Enfield, Connecticut, on Sunday, March 14, 2010. For a list of stolen medicines see the above link. Product from the affected lots which had been delivered from Lilly to retailers, wholesalers or institutions prior to March 14 was approved for its intended use and is not affected by this event. Product containing these lot numbers has been distributed by Lilly within the United States, Puerto Rico and its territories. These medicines require a prescription for purchase. Consumers should purchase Lilly products only from well-established and reputable retailers. Lilly recommends that consumers always inspect the product and label for signs of tampering before opening. Lilly is advising practitioners, retailers and consumers to check all pharmaceutical products for signs of tampering or damage prior to purchase and/or use. Pharmacists and other health care professionals should not use the product if it has been removed from the sealed bottle or container, if the induction seal has been compromised, or in the case of glass vials, if the flip cap appears to have been disturbed in any way.